Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty

December 6, 2021 updated by: Hilal Maradit Kremers, Mayo Clinic

Risk of Dementia and Heart Failure in Total Joint Arthroplasty

The purpose of this research is to understand whether patients who previously had total hip or total knee replacement experience memory, thinking or heart problems. This study will help us determine if and how often these problems occur.

Study Overview

Detailed Description

At your first visit you will be asked to do the following.

  • Sign this informed consent document.
  • Questionnaire: You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities.
  • Interview: The interview will be performed by the study coordinator who is a member of the research team. It will take about 20-30 minutes to complete. You will be asked to answer questions about your general health, surgeries, medications, and your memory and thinking skills.
  • Memory Interview: You will have an evaluation of your memory and thinking skills. You will answer questions and perform tasks that evaluate various thinking abilities such as concentration, memory, reasoning, and learning.
  • Blood draw: Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests.
  • Magnetic Resonance Imaging (MRI) of your brain (optional): If you agree to participate, you will be asked to have MR imaging of your brain.
  • Echocardiogram: You will be asked to have an echocardiogram of your heart.
  • Follow-up visit in 2-3 years: You will be asked to return to Mayo for your second study visit in 2-3 years. At this visit, you will be asked to complete the same memory and thinking tests described for the first visit. You will also be asked to repeat the echocardiogram.

Study Type

Observational

Enrollment (Actual)

115

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

100 patients to complete cardiology part of the study (questionnaires, blood test, echocardiogram).

100 patients to complete cognitive part of the study (questionnaires, interviews, blood test, MRI).

Patient groups may overlap.

Description

Inclusion Criteria:

  • Patient is willing to sign consent
  • Patients scheduled for revision surgery for osteolysis, aseptic loosening, or wear of TJA implants/ALTR.

OR

-MCSA (Mayo Clinic Study of Aging) patients with THA or TKA with at least 10 years since surgery.

Exclusion Criteria:

  • History of dementia
  • History of cardiomyopathy or heart failure
  • Revision for infection or fracture
  • Patient is pregnant
  • Patient has medication patches on
  • Patient has a pacemaker or defibrillator (ICD)
  • Patient has a deep brain stimulator (DBS)
  • Patient has a vagal neuro stimulator (VNS)
  • Patient has any other kind of neuro stimulator
  • Patient has aneurysm clips in their head
  • Patient has a tissue expander
  • Patient has had a gastrointestinal clip or pill camera inserted in the last 90 days
  • Patient has an esophageal reflux management system (LINX)
  • Patient has a cochlear (ear) or auditory implant
  • Patient has any implanted device (electronic or not) with magnets
  • Patient has an eye injury involving metal
  • Patient has allergy to contrast or dye

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Metallosis Patients
Patients who are being seen by surgeons for metal-related issues in the blood, pain, or revision surgery.
You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities.
Behavioral and Memory interviews will take place with the patient.
Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests.
Each MR examination takes about 45 minutes and does not require the use of needles, medication or contrast enhancement. You will lie on your back and enter the MR scanner for the study, during which time you will hear knocking noises. People with pacemakers, aneurysm clips, cochlear implants, or metal/foreign objects in their eyes are not permitted to undergo MR studies. We will review your implants and determine your eligibility.
Other Names:
  • MRI
Each echocardiogram takes about 30 minutes. This test uses sound waves to look at your heart. The person doing the test will press on your chest with a machine to obtain the pictures. The pressure may be uncomfortable. The echocardiogram will involve an image enhancement agent infusion to obtain better images.
Control Group
Patients who have had total hip or knee arthroplasty no less than 5-10 years ago, who have no symptoms.
You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities.
Behavioral and Memory interviews will take place with the patient.
Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests.
Each MR examination takes about 45 minutes and does not require the use of needles, medication or contrast enhancement. You will lie on your back and enter the MR scanner for the study, during which time you will hear knocking noises. People with pacemakers, aneurysm clips, cochlear implants, or metal/foreign objects in their eyes are not permitted to undergo MR studies. We will review your implants and determine your eligibility.
Other Names:
  • MRI
Each echocardiogram takes about 30 minutes. This test uses sound waves to look at your heart. The person doing the test will press on your chest with a machine to obtain the pictures. The pressure may be uncomfortable. The echocardiogram will involve an image enhancement agent infusion to obtain better images.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mild Cognitive Impairment
Time Frame: 1 year
Cognitive impairment as assessed through interviews
1 year
Brain MRI findings
Time Frame: 1 year
imaging
1 year
Left ventricular dysfunction
Time Frame: 1 year
heart dysfunction as assessed using echocardiography
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Hilal Maradit Kremers, MD, Principal Investigator

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

September 27, 2021

Study Completion (Actual)

September 27, 2021

Study Registration Dates

First Submitted

November 7, 2019

First Submitted That Met QC Criteria

November 14, 2019

First Posted (Actual)

November 18, 2019

Study Record Updates

Last Update Posted (Actual)

December 8, 2021

Last Update Submitted That Met QC Criteria

December 6, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 19-001294
  • R01AG060920 (U.S. NIH Grant/Contract)
  • R01HL147155 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Questionnaires

3
Subscribe